MGMT and glioblastoma: Epigenetic silencing of the MGMT promoter by methylation compromises MGMT-based DNA repair, leading to longer survival rates after TMZ administration, whereas if the MGMT promoter is unmethylated, it is associated with TMZ resistance in some, but not all, GBM tumors.